✦ LIBER ✦

A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumors

✍ Scribed by Jordan D. Berlin; Dona B. Alberti; Rhoda Z. Arzoomanian; Chris A. Feierabend; Kris J. Simon; Kim A. Binger; Rebecca M. Marnocha; George Wilding

Book ID: 110233440
Publisher: Springer US
Year: 1998
Tongue: English
Weight: 63 KB
Volume: 16
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1006242005837

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of gemcitabine and docet

A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors

✍ David P. Ryan; Thomas J. Lynch; Michael L. Grossbard; Michael V. Seiden; Charles 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

A Phase I study was initiated to determine the maximum tolerated dose of weekly gemcitabine combined with monthly, fixed-dose docetaxel. ## METHODS. Patients with metastatic solid tumors were treated with docetaxel, 60 mg/m 2 , on Day 1 every 28 days. Gemcitabine was administered on Days 1, 8, and

Phase II study of 5-fluorouracil/leucovo

Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors

✍ Charles B. Pratt; William H. Meyer; Nanna Howlett; Edwin C. Douglass; Laura C. B 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 512 KB

Phase I study of gefitinib, irinotecan,

Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer

✍ Jeffrey A. Meyerhardt; Jeffrey W. Clark; Jeffrey G. Supko; Joseph P. Eder; Shuji 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 329 KB

Phase II trials of 5-fluorouracil and le

Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma

✍ Joseph Rubin; James G. Gallagher; Georgene Schroeder; Allan J. Schutt; Robert J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 3 views

Conducted as a collaborative trial of North Central Cancer Treatment Group and Mayo Clinic.

Phase I dose-escalation study of tezacit

Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors

✍ Johanna C. Bendell; Joseph P. Eder; Jeffrey W. Clark; Panagiotis Fidias; Thomas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

A pharmacokinetic interaction study of d

A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumors

✍ A. Felici; W. J. Loos; J. Verweij; I. Cirillo; P. de Bruijn; K. Nooter; R. H. J. 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 283 KB